For the quarter ending 2026-03-31, CDIOW made $2,680 in revenue. -$1,788,158 in net income. Net profit margin of -66722.31%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 2,680 | -670* | 2,855 | 7,475 |
| General and administrative | 1,455,497 | 1,029,630.75* | - | - |
| Sales and marketing | 196,712 | 191,722* | - | - |
| Research and development | 129,776 | 160,303* | - | - |
| Selling, general and administrative expenses | - | - | 1,714,452 | 1,686,174 |
| Amortization | 5,532 | 16,308.25* | - | - |
| Total operating expenses | 1,787,517 | 1,397,964* | 1,714,452 | 1,686,174 |
| Loss from operations | -1,784,837 | -1,398,634* | -1,711,597 | -1,678,699 |
| Interest income | 118 | 143.5* | 189 | 190 |
| Interest expense | 3,439 | 3,074* | 3,128 | 4,690 |
| Total other (expenses) | -3,321 | -2,930.5* | -2,939 | -4,500 |
| Loss before provision for income taxes | -1,788,158 | -1,401,564.5 | -1,714,536 | -1,683,199 |
| Provision for income taxes | - | - | - | 0 |
| Net loss | -1,788,158 | -1,401,564.5 | -1,714,536 | -1,683,199 |
| Basic EPS | -0.63 | -0.798 | -0.98 | -0.97 |
| Diluted EPS | -0.63 | -0.798 | -0.98 | -0.97 |
| Basic Average Shares | 2,840,778 | 1,757,306 | 1,757,900 | 1,739,045 |
| Diluted Average Shares | 2,840,778 | 1,757,306 | 1,757,900 | 1,739,045 |
Cardio Diagnostics Holdings, Inc. (CDIOW)
Cardio Diagnostics Holdings, Inc. (CDIOW)